Results 231 to 240 of about 13,648,107 (360)

Immunotherapy for renal cell carcinoma: New therapeutic combinations and adverse event management strategies: A review. [PDF]

Medicine (Baltimore)
Ma X, Chen J, Chen S, Lan X, Wei Z, Gao H, Hou E.   +6 more
europepmc   +1 more source

Construction of New Value Chain Management and Various BOMs for Research Project of SDGs Food Loss Reduction: Case Studies on Circular Economy Sweets Product Planning, Sales Event Holding, and Questionnaire Surveys

, 2022
Qian Mijia, Kinya Tamaki
openalex   +1 more source

Online Conferencing to facilitate constructive alignment in Sports Event Management [PDF]

, 2008
Goodwin, Kelly
core  

Online microbial fingerprinting for quality management of drinking water : full-scale event detection

, 2020
Boon, Nico, Buysschaert, Benjamin, De Gusseme, Bart, Favere, Jorien   +3 more
core   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. [PDF]

Clin Cancer Res
Meric-Bernstam F, Hollebecque A, Furuse J, Oh DY, Bridgewater JA, Shimura M, Anderson B, Hangai N, Wacheck V, Goyal L.   +9 more
europepmc   +1 more source

Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management

, 2015
Pei‐Han Kao, Jen‐Shi Chen, Wen‐Hung Chung, Rosaline Chung‐Yee Hui, Chih-Hsun Yang   +4 more
openalex   +2 more sources

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management. [PDF]

Clin Transl Oncol
Ciruelos E, García-Sáenz JÁ, Gavilá J, Martín M, Rodríguez CA, Rodríguez-Lescure Á.   +5 more
europepmc   +1 more source

CONCEPTS OF RISK MANAGEMENT RESEARCH AS A BASIS FOR UNDERSTANDING THE REDUCTION OF RISK EVENTS OF PHARMACEUTICAL ORGANIZATIONS

, 2022
Андрей Георгиевич Петров, Виктор Андреевич Семенихин, Сергей Николаевич Филимонов, Юлия Александровна Сашко, Николай Владимирович Абрамов, Ольга Владимировна Хорошилова, Андрей Александрович Марьин   +6 more
openalex   +1 more source